Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St. North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved By OMB
|Title of collection||OMB control number||Date approval expires|
|Web-Based Pilot Survey to Assess Allergy to Cosmetics in the United States||0910-0881||1/31/2021|
|Postmarket Surveillance of Medical Devices||0910-0449||11/30/2022|
|Administrative Procedures for Clinical Laboratory Improvement Amendments Categorization||0910-0607||11/30/2022|
|Start Printed Page 5447|
|Requirements Under the Comprehensive Smokeless Tobacco Health Education Act of 1986, as Amended by the Family Smoking Prevention and Tobacco Control Act||0910-0671||11/30/2022|
|Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act||0910-0827||11/30/2022|
|Experimental Study on Measuring Consumer Comprehension of Displays of Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke||0910-0880||11/30/2022|
|Medical Devices; Current Good Manufacturing Practice Quality System Regulation||0910-0073||12/31/2022|
|Threshold of Regulation for Substances Used in Food-Contact Articles||0910-0298||12/31/2022|
|Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents||0910-0312||12/31/2022|
|Format and Content Requirements for Over-the-Counter Drug Product Labeling||0910-0340||12/31/2022|
|Product Jurisdiction: Assignment of Agency Component for Review of Premarket Applications||0910-0523||12/31/2022|
|Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition||0910-0541||12/31/2022|
|Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims||0910-0670||12/31/2022|
|Guidance for Tobacco Retailers on Tobacco Retailer Training Programs||0910-0745||12/31/2022|
|Dear Health Care Provider Letters: Improving Communication of Important Safety Information||0910-0754||12/31/2022|
|Requests for Feedback on Medical Device Submissions||0910-0756||12/31/2022|
|Data to Support Social and Behavioral Research as Used by the Food and Drug Administration||0910-0847||12/31/2022|
End Supplemental Information
Dated: January 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-01655 Filed 1-29-20; 8:45 am]
BILLING CODE 4164-01-P